Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Country / region: Turkey (Türkiye) Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20081
20091
20101
20122
20134
20141
20153
20163
20171
20181
20193
20204
20213
20221
20232
20244
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated6
Active, not recruiting5
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen7
Novartis Pharmaceuticals5
Hoffmann-La Roche3
Firat University2
Hacettepe University2
Novartis2
Tanabe Pharma Corporation2
Amgen1
Antalya Training and Research Hospital1
Asuman Kucukoner1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting42
Multiple Sclerosis25
Fatigue5
Anxiety Disorders2
Demyelinating Diseases2
Autoimmune Diseases1
Chronic Pain1
Cognitive Dysfunction1
Diffuse Cerebral Sclerosis of Schilder1
Fatigue Syndrome, Chronic1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.